Workflow
Psychedelic stocks
icon
Search documents
Definium Therapeutics Inc (DFTX) Says Cash Enough to Fund Operations into 2028
Yahoo Finance· 2026-03-25 05:34
Group 1 - Definium Therapeutics Inc (NASDAQ:DFTX) is recognized as a promising psychedelic stock for investment in 2026, with its lead drug candidate DT120 in Phase 3 trials targeting major depressive disorder (MDD) and generalized anxiety disorder (GAD) [1][5] - The company plans to host an Investor and Analyst Day on April 22 to discuss updates on the DT120 program and explore commercial opportunities [2] - In 2025, the company reported R&D expenditures of $117.7 million and general administrative costs of $48.6 million, ending the year with $411.6 million in cash and equivalents, sufficient to fund operations until 2028 [3][8] Group 2 - Enrollment for the Emerge Phase 3 MDD trial for DT120 has been completed, with topline data expected in late Q2 2026; enrollments for two Phase 3 GAD trials are also progressing well [4] - The Phase 2a trial for DT402, which targets autism spectrum disorder, began in Q4 2025, with initial data anticipated in 2026 [4]
This couple bet wedding cash on Reddit-hyped psychedelic stocks. Here’s how online hype can push investors into risk
Yahoo Finance· 2026-01-24 11:45
Core Insights - Young investors are increasingly using social media and Reddit forums for investment ideas, often prioritizing quick returns over understanding investment fundamentals and associated risks [1][2][4] - A couple invested a significant portion of their wealth, approximately $160,000 or two-thirds of their portfolio, in Bitcoin and psychedelic stocks, highlighting a trend of high-risk investment strategies among new investors [2][3] - Experts caution that concentrating wealth in speculative and volatile investments, such as psychedelic stocks and cryptocurrencies, can lead to substantial financial losses [3][6][7] Psychedelic Stocks - Psychedelic stocks refer to publicly traded companies involved in the research, development, and commercialization of psychedelic-based therapies for mental health and neurological conditions [5] - The appeal of psychedelic stocks lies in their potential for high returns, with some companies potentially worth billions if they succeed, although many are still pre-revenue and face significant risks [6] Investment Strategies - Diversification is a fundamental investment principle, which involves spreading investments across different asset types to mitigate risk; however, pairing speculative investments like psychedelic stocks with cryptocurrencies does not adhere to this principle [7]